Literature DB >> 17244338

Modified method of AgNOR staining for tissue and interpretation in histopathology.

Mulazim Hussain Bukhari1, Shahida Niazi, Saeed Akhter Khan, Ihsanulla Hashmi, Shahida Perveen, Shahzad Shafqat Qureshi, Naseer Ahmed Chaudhry, G R Qureshi, Mumtaz Hasan.   

Abstract

This study was conducted in the department of Pathology King Edward Medical University, from June to December 2002 to introduce the new method of AgNOR staining and its interpretation to increase its reliability. A total of 60 brain specimens were stained with modified AgNOR technique. The diagnosis of malignancy was made on H &amp; E staining. AgNOR counts, variation in size and dispersion of AgNOR dots in cells were graded and compared in malignant and non-malignant lesions. Modified method of AgNOR staining and interpretation was an easy, reliable and reproducible alternative to traditional AgNOR techniques for evaluating proliferation activity of cells in malignant and benign brain lesions. mAgNOR counts of different grades of astrocytoma (2.97+/-0.96, 3.97+/-0.43, 6.01+/-2.74 and 8.01+/-3.56) were significantly (P<0.01) greater when compared with counts of normal brain (0.40+/-0.01), and reactive gliosis (0.60+/-0.01). AgNOR size and dispersion were of higher grade in a significantly greater proportion of malignancy when compared with benign conditions (P<0.05). The AgNOR dots were brighter and more clear with modified staining when compared with previous studies. We conclude that modified AgNOR staining technique is simple, quick and reliable to evaluate cell proliferation by detecting AgNORs size and dispersion. In future, AgNOR size and dispersion should be considered rather than the count only. We recommend the use of morphometry for AgNOR size in future. We also recommend the use of modified AgNOR staining for obtaining sound and confidant results in routine paraffin sections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244338      PMCID: PMC2517289          DOI: 10.1111/j.1365-2613.2006.00522.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  14 in total

1.  Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies.

Authors:  A Pich; L Chiusa; F Marmont; N Cappello; R Navone
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  Interphase nucleolar organizer regions in cancer cells.

Authors:  M Derenzini; D Ploton
Journal:  Int Rev Exp Pathol       Date:  1991

3.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

4.  Formation and detection of RNA-DNA hybrid molecules in cytological preparations.

Authors:  J G Gall; M L Pardue
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

5.  AgNORs in hyperplasia, papilloma and oral squamous cell carcinoma.

Authors:  L M Fonseca; M A do Carmo
Journal:  Braz Dent J       Date:  2000

6.  Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.

Authors:  A Pich; L Chiusa; E Margaria
Journal:  Cancer Detect Prev       Date:  1995

7.  Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.

Authors:  B Helpap; L Loesevitz; A Bulatko
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.

Authors:  A Pich; L Chiusa; A Comino; R Navone
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas.

Authors:  A Bànkfalvi; K Schmitz; T Mock; M Kemper; C Cubick; W Böcker
Journal:  Anal Cell Pathol       Date:  1998       Impact factor: 2.916

10.  AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.

Authors:  M Tomobe; T Shimazui; K Uchida; H Akaza
Journal:  Anal Cell Pathol       Date:  2001       Impact factor: 2.916

View more
  5 in total

1.  Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.

Authors:  Hayam A Aiad; Manar A Bashandy; Asmaa G Abdou; Ahmad A Zahran
Journal:  Pathol Oncol Res       Date:  2012-10-11       Impact factor: 3.201

2.  Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Acute Leukemia in Adults.

Authors:  Małgorzata Gajewska; Elżbieta Rutkowska; Iwona Kwiecień; Piotr Rzepecki; Kazimierz Sułek
Journal:  Diagnostics (Basel)       Date:  2022-03-28

3.  Adaptation of the agyrophil technique for nucleolar organizer regions to canine peripheral blood smears.

Authors:  John Ogunsola; Richard Antia
Journal:  Open Vet J       Date:  2018-05-25

4.  Roles of Proliferation and Angiogenesis in Locally Aggressive Biologic Behavior of Ameloblastoma versus Ameloblastic Fibroma.

Authors:  Amr Ibrahim; Emad Alqalshy; Ahmed Abdel-Shakour Abdel-Hafiz; Kamal Abd El-Rahman; Magdy Alazzazi
Journal:  Diagnostics (Basel)       Date:  2022-02-03

5.  Role of Multiparameter Analysis of AgNORs in FNA Smears of Thyroid Swellings in Differentiating Benign and Malignant Lesions.

Authors:  Mohammad Ismail Hossain; Md Quamrul Hassan; Pradip Bhattacharjee; M Shahab Uddin Ahamad; Zillur Rahman
Journal:  Patholog Res Int       Date:  2012-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.